微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.26% | -91.69% | -92.68% | 97/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.55% | -76.08% | 5.65% | 72/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 3.36% | -69.48% | -30.15% | 74/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.81% | -49.26% | 53.67% | 42/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.13% | -36.51% | -78.91% | 25/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 14.84% | 10.25% | 34.79% | 11/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 11.01% | 10.1% | 16.14% | 20/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 9.48% | 43.42% | 92.29% | 10/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.93% | 130.37% | -63.37% | 15/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 13.46% | 17.97% | 34.6% | 48/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 10% | 1.83% | 51.29% | 55/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.61% | 1.69% | 208.88% | 58/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.14% | -14.06% | -81.24% | 67/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 11.41% | 273.93% | 16.19% | 72/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 9.82% | 419.58% | 51.08% | 61/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.5% | 3321.05% | 161.04% | 64/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.49% | 522.03% | 137.96% | 61/131 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -6.56% | -221.93% | -447.09% | 121/131 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 1.89% | -60.29% | 894.74% | 79/131 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 0.19% | -95.24% | 132.2% | 101/131 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | -0.59% | -164.84% | -110.97% | 70/131 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 5.38% | -71.12% | 13.03% | 96/131 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.76% | -68.25% | 19.3% | 49/131 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 3.99% | -54.97% | 338.46% | 51/131 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.91% | -53.57% | -95.12% | 43/131 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 18.63% | 1.75% | 24.28% | 36/131 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 14.99% | 13.82% | 69.19% | 9/131 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 8.86% | 3.02% | 352.04% | 9/131 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 1.96% | 41.01% | -89.3% | 32/131 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 18.31% | 16.77% | 39.03% | 36/131 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 13.17% | 141.21% | 53.14% | 11/131 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 8.6% | 2% | 518.71% | 14/131 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.39% | 37.62% | -91.14% | 33/131 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 15.68% | -14.22% | 187.18% | 35/131 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 5.46% | 2% | -70.13% | 27/131 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2015-12-31 | 18.28% | -36.57% | 1709.9% | 18/131 | 15.95% | 明德生物 | 23.29% | 行业排名> |
| 2015-03-31 | 1.01% | 2% | -96.5% | 29/131 | 3.2% | 健帆生物 | 7.75% | 行业排名> |